Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2020 09:00 ET | Source: Vystar Corp.

Summit Academy Embraces Science of RxAir UV Light Air Purifiers to Reduce COVID-19 Risk

Worcester, MA, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Savvy administrators at Summit Academy in Worcester, Mass., are looking to science to help prevent COVID-19 infection as they enter the new school...
August 06, 2020 12:54 ET | Source: Vystar Corp.

Vystar Contracts Partners for Production of Rx3000 UV Light Air Purifiers that Inactivate Airborne Viruses

New manufacturer offers “Made in the USA” expanded production capacity, quality & fast deliveryRx3000® FDA certified Class II Medical device inactivates 99.97% of harmful airborne viruses &...
July 22, 2020 09:47 ET | Source: Vystar Corp.

Vystar Introduces RxAir400 UV-C Light Germicidal Air Purifier Extended Life UV Bulb, Wall Mount Option

Global air purifier market expected to grow to $90 billion with analysts projecting CAGR between 10 and 42%New RxAir400 Pro UV-C bulb replacement cartridge provides 18,000 vs 9,000 hr. use.Wall mount...
July 20, 2020 07:30 ET | Source: Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line

WAKEFIELD, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, reports today receiving new data from ongoing...
July 16, 2020 09:07 ET | Source: Vystar Corp.

Vystar to Produce RxAir400 UV-C Light Air Purifiers with New Manufacturer

CDC reports UV-C Light Germicidal Irradiation (UVGI) as one of “most promising methods" for Coronavirus decontamination of facemasks.1 RxAir400 employs powerful UVGI proven to inactivate >99.9% of...
July 13, 2020 12:06 ET | Source: InductiveHealth Informatics

InductiveHealth Appoints Alexis Sulyma as New Chief Growth Officer

ATLANTA, July 13, 2020 (GLOBE NEWSWIRE) -- InductiveHealth Informatics (InductiveHealth), a public health technology firm known for bringing innovation to the public health informatics industry and...
July 13, 2020 08:00 ET | Source: Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020

WAKEFIELD, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides perspectives on the planned...
July 07, 2020 08:00 ET | Source: Innovation Pharmaceuticals Inc.

In Vitro Testing of Innovation Pharmaceuticals’ Brilacidin for COVID-19 Shows Consistent Anti-SARS-CoV-2 Efficacy; Manufacturing Preparation Underway for COVID-19 Clinical Trial

WAKEFIELD, Mass., July 07, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today reports the latest developments related...
June 17, 2020 07:30 ET | Source: Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line

Data From Ongoing Testing at U.S. Regional Biocontainment Laboratory Data adds to growing body of research in both human and animal cell lines supporting Brilacidin’s robust antiviral properties...
June 11, 2020 07:30 ET | Source: Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Collaborating with Regional Biocontainment Lab on Grant Application to Research Brilacidin as a Pan-Coronavirus Therapeutic

WAKEFIELD, Mass., June 11, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announces today the Company and researchers...